Information  X 
Enter a valid email address

Danakali Limited (DNK)

  Print      Mail a friend

Thursday 03 January, 2019

Danakali Limited

Update on Issue of Equity and Total Voting Rights

RNS Number : 0906M
Danakali Limited
03 January 2019
 

Announcement

Thursday, 3 January 2019

 

Update on Issue of Equity and Total Voting Rights and Capital

 

Danakali Limited (ASX: DNK / LSE: DNK) (Danakali, or the Company) advises that application has been made to the UK Listing Authority for the admission of the 8,571 new Ordinary Shares issued and allotted per the announcement released on 21 December 2018 to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's Main Market for listed securities. It is expected that dealings will commence on 4 January 2019. The new Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares in issue.

 

In accordance with the FCA's Disclosure and Transparency Rule 5.6.1(R), the Company confirms that as at 31 December 2018, the Company's issued share capital comprises 264,422,398 ordinary shares of no par value, with each share carrying the right to one vote. The Company does not hold any ordinary shares in treasury.

 

The above figure of 264,422,398 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or of a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

 

 

For more information, please contact:

 

Danakali

 

Seamus Cornelius

Executive Chairman

+61 8 6315 1444

William Sandover

Head of Corporate Development & External Affairs

+61 499 776 998

 

Corporate Broker - Numis Securities

 

UK IR/PR - Instinctif Partners

John Prior / Matthew Hasson / James Black /

Paul Gillam

+44 (0)20 7260 1000

David Simonson / George Yeomans /

Sarah Hourahane

[email protected]

+44 (0)207 457 2020

 

 

 

- - - ENDS - - -


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCQXLBBKFFZBBD

a d v e r t i s e m e n t